“…PolyMPC is becoming recognized as perhaps the most biocompatible of synthetic polymers, naturally leading to various successful applications including, for example, contact lenses, stents, and various medical devices and implants. [47][48][49][50][51][52][53] Advances in controlled free radical polymerization, especially copper-catalyzed atom transfer radical polymerization (ATRP), are enabling the preparation of novel polyMPC derivatives appropriate for conjugation to therapeutic proteins (Fig. 3).…”